about
Mini-Cog for the diagnosis of Alzheimer’s disease dementia and other dementias within a primary care settingAD-8 for diagnosis of dementia across a variety of healthcare settingsCytidine 5'-Diphosphocholine (Citicoline) in Glaucoma: Rationale of Its Use, Current Evidence and Future PerspectivesResearch in people with psychosis risk syndrome: a review of the current evidence and future directionsLong-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease.Therapy for Alzheimer's Disease: How Effective are Current Treatments?N-acetylcysteine prevents 4-hydroxynonenal- and amyloid-beta-induced modification and inactivation of neprilysin in SH-SY5Y cellsAdding memantine to rivastigmine therapy in patients with mild-to-moderate alzheimer's disease: results of a 12-week, open-label pilot study.Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology.Memantine prevents cardiomyocytes nuclear size reduction in the left ventricle of rats exposed to cold stress.Targeting glutamatergic signaling for the development of novel therapeutics for mood disordersAltering neuronal excitability to preserve network connectivity in a computational model of Alzheimer's disease.Memantine for the Treatment of Dementia: A Review on its Current and Future Applications.The antioxidant xanthorrhizol prevents amyloid-β-induced oxidative modification and inactivation of neprilysin.Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis
P2860
Q24187527-2EFF00A8-4E70-4F1B-A619-9C92A9600219Q24194796-0B0AEA51-86AE-40F5-8B51-69AED75664CEQ26775083-3D9BF810-8B1C-479C-9FB2-0990BD77709BQ30475598-79A1444A-61A6-424E-866E-8CFBB92B9DA4Q33662471-08E91645-65B6-49F7-BB8E-9AFE3135F73EQ34409349-8CA4FDB8-988B-4085-BE46-B5B46FF2BFD3Q34581928-B5717A2C-99F9-47D9-975A-A5FFF4D81991Q35574508-ED827A6F-EA3F-49DA-834C-451D47F2EB38Q35770190-B917BD61-2993-4126-8B01-84316E8388B3Q37349531-485B8E28-F83E-44AC-9D77-727DCAADD289Q37481603-6C96E337-6992-4340-9CB4-E099933741C7Q42370244-AED6F53B-2BF1-4A90-9A2D-AD2D1C42AFE3Q47280369-BCE14B05-8CBB-4E66-88A9-ED0E609760ADQ50059412-896C1482-6AA4-43B6-A816-8D17786BBF15Q57072685-AC0A82B2-4B4F-4166-BF9A-8F3FA32F7918
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Memantine for dementia
@ast
Memantine for dementia
@en
Memantine for dementia
@en-gb
Memantine for dementia
@nl
type
label
Memantine for dementia
@ast
Memantine for dementia
@en
Memantine for dementia
@en-gb
Memantine for dementia
@nl
altLabel
Memantine for dementia.
@en
prefLabel
Memantine for dementia
@ast
Memantine for dementia
@en
Memantine for dementia
@en-gb
Memantine for dementia
@nl
P2093
P1476
Memantine for dementia
@en
Memantine for dementia.
@en
P2093
F Sherriff
S A Areosa
Sastre A Areosa
P304
P356
10.1002/14651858.CD003154
P407
P577
2003-01-01T00:00:00Z
2003-07-21T00:00:00Z